Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates on sitafloxacin and ertapenem for acute urinary tract infections due to E. coli or Klebsiella in post-kidney transplant patients; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Escherichia Coli Infections
• Kidney Transplantation
• Klebsiella Infections
• Urinary Tract Infection
• Urinary Tract Infections

Drugs mentioned

• ERTAPENEM (ertapenem)
• Sitafloxacin (sitafloxacin)

Snippet

Sponsor: Khon Kaen University | Conditions: Anti-Infective Agents, Urinary, Escherichia Coli Infections | Phase 2, Phase 3 | Status: UNKNOWN